PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 Months

NCT07333352 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infectious Disease

Interventions

BIOLOGICAL: 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine (RZ700)
BIOLOGICAL: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (Prevnar 13)

Sponsor

Shanghai Reinovax Biologics Co.,LTD